Samantha Lefland
Lawyers
Advises on IP and technology matters, including strategic commercial and licensing arrangements, mergers, acquisitions and other corporate transactions.
Samantha advises clients on a wide range of IP and technology-related corporate and commercial transactions, including licensing and collaboration agreements, supply and distribution agreements and other strategic commercial agreements. She also advises on the IP and technology-related aspects of M&A transactions, joint ventures, financings, restructurings and capital markets offerings.
Experience highlights
Recent Representations
- GSK exclusive license agreement with Hansoh Pharma
- GSK collaboration extension and new data licensing agreement with 23andMe
- Fiserv $2 billion notes offering
- BMS $35 million investment in Immatics
- Centogene strategic collaboration with Lifera
- Fiserv €800 million notes offering
- GSK exclusive licensing agreement with Scynexis
- Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
- Fiserv $1.8 billion notes offering
- QUALCOMM $1.9 billion notes offering
- Qualcomm $1.5 billion notes offering
- Comcast streaming platform JV with Charter
- IHS Markit sells Base Chemicals business to News Corp
- Digicel Group $1.85 billion sale of Pacific operations to Telstra
- Spectrum Brands $4.3 billion sale of its Hardware & Home Improvement segment
- State Street $3.5 billion acquisition of Brown Brothers Harriman Investor Services
Insights
Education
J.D., Stanford Law School
- Executive Editor, Stanford Law Review
B.S., Policy Analysis and Management, Cornell University
Professional history
- Counsel, 2022-present
- Davis Polk since 2015
Qualifications and admissions
- State of New York